Contributions of meta-analyses based on individual patient data to therapeutic progress in colorectal cancer

International Journal of Clinical Oncology

Volumn 14, Issue 2, 2009, Pages 95-101

  Buyse, Marc ^a,b  

^a INTERNATIONAL DRUG DEVELOPMENT INSTITUTE   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

Author keywords

Colorectal cancer; Meta analysis

Indexed keywords

ALPHA INTERFERON; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; METHOTREXATE;

ADVANCED CANCER; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RESEARCH; CLINICAL RESEARCH; CLINICAL TRIAL; COLORECTAL CANCER; COLORECTAL TUMOR; CONTINUOUS INFUSION; COST EFFECTIVENESS ANALYSIS; HUMAN; MEDICAL INFORMATION; META ANALYSIS; OVERALL SURVIVAL; PATIENT CODING; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT;

BIOLOGICAL MARKERS; CLINICAL TRIALS AS TOPIC; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; HUMANS; META-ANALYSIS AS TOPIC;

EID: 65349128989     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-009-0879-2     Document Type: Review

References (50)

1. Chalmers T, Buyse M (1988) Meta-analysis. In: Chalmers TC (ed) Data analysis for clinical medicine: the quantitative approach to patient care in gastroenterology. International University Press, Rome, Italy, pp 75-84
2. M. Buyse 2005 Meta-analysis S.R. Wilson C.J. Burden Modern biometry EOLSS Oxford, UK Buyse M (2005) Meta-analysis. In: Wilson SR, Burden CJ (eds) Modern biometry; In: Encyclopedia of life support systems (EOLSS). EOLSS, Oxford, UK. http://www.eolss.net
3. M. Buyse P. Piedbois Y. Piedbois R. Carlson 2000 Meta-analysis: methods, strengths and weaknesses Oncology 14 437 443
4. M. Buyse P. Piedbois 1993 Meta-analyses, use and misuse (letter to the editor) J Clin Oncol 11 382
5. M. Buyse R.W. Carlson P. Piedbois 1999 Meta-analyses of published results are unreliable (letter to the editor) J Clin Oncol 16 1646 1647
6. P. Piedbois M. Buyse 2004 Meta-analyses based on abstracted data: a step in the right direction, but only a first step (editorial) J Clin Oncol 22 3839 3841 (Pubitemid 41079861)
7. M. Buyse L.M. Ryan 1987 Issues of efficiency in combining proportions of deaths from several clinical trials Stat Med 6 565 576
8. M. Buyse A. Zeleniuch-Jacquotte T. Chalmers 1988 Adjuvant therapy of colorectal cancer: why we still don't know JAMA 259 3571 3578 (Pubitemid 18158052)
9. L. Stewart M. Clarke 1995 on behalf of the Cochrane Working Group on meta-analysis using individual patient data. Practical methodology of meta-analyses (overviews) using updated individual patient data Stat Med 14 2057 2079
10. P. Piedbois M. Buyse 1994 Meta-analyses need time, collaboration and funding (letter to the editor) J Clin Oncol 12 878 879 (Pubitemid 24110933)
11. L. Zelek P. Piedbois M. Buyse 2002 Contribution of metaanalyses to the evaluation of treatments for advanced colorectal cancer Expert Rev Anticancer Ther 2 417 425
12. Advanced Colorectal Cancer Meta-Analysis Project 1992 Modulation of 5-fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate J Clin Oncol 10 896 903
13. P. Piedbois M. Buyse 1993 What can we learn from a meta-analysis of trials testing the modulation of 5-fluorouracil by leucovorin? Ann Oncol 4 Suppl2 S15 S19 (Pubitemid 23227820)
14. M. Buyse 1993 Meta-analysis of randomized clinical trials in cancer Gan To Kagaku Ryoho (Jpn J Cancer Chemother) 20 2501 2506 (Pubitemid 24059439)
15. Advanced Colorectal Cancer Meta-Analysis Project 1994 Metaanalysis of randomized trials testing the biochemical modulation of 5-fluorouracil by methotrexate in metastatic colorectal cancer J Clin Oncol 12 960 969 (Pubitemid 24145323)
16. Meta-Analysis Group In Cancer 1998 Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer J Clin Oncol 16 301 308 (Pubitemid 28041613)
17. Meta-Analysis Group In Cancer 1996 Reappraisal of hepatic arterial infusion in the treatment of non resectable liver metastases from colorectal cancer J Natl Cancer Inst 88 252 258 (Pubitemid 26073369)
18. P. Piedbois M. Buyse 2000 Recent meta-analyses in colorectal cancer Curr Opin Oncol 12 362 367 (Pubitemid 32043975)
19. Meta-Analysis Group In Cancer 2004 Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis J Clin Oncol 22 3766 3775 (Pubitemid 41095217)
20. Piedbois P, Buyse M (2002) Fluoropyrimidines in advanced colorectal cancer: a review of six consecutive meta-analyses. In: Rustum YM (ed) Fluoropyrimidines in the treatment of colorectal cancer. Humana, Totowa, NJ, pp 183-190
21. P. Thirion N. Wolmark E. Haddad for the Meta- Analysis Group In Cancer 1999 Survival impact of chemotherapy in patients with liver metastases confined to the liver: a meta-analysis of 1458 non-operable patients randomised in 22 trials and 4 metaanalyses Ann Oncol 10 1317 1320
22. P. Thirion P. Piedbois M. Buyse for the Meta-Analysis Group In Cancer 2001 Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancer Br J Cancer 84 611 620 (Pubitemid 32238993)
23. Colorectal Cancer Collaborative Group 2001 Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomized trials Lancet 358 1291 1304 (Pubitemid 33016492)
24. J. Sakamoto Y. Ohashi C. Hamada for the Meta- Analysis Group of the Japanese Society for Cancer of the ColonRectumthe Meta-Analysis Group In Cancer 2004 Efficacy of oral fluorinated pyrimidines as adjuvant therapy after resection of colorectal cancer: 5-year results from three randomised trials in 5233 patients J Clin Oncol 22 484 492
25. Liver Infusion Meta-Analysis Group 1997 Portal vein infusion of cytotoxic drugs after colorectal cancer surgery: a meta-analysis of ten randomized studies involving 4000 patients J Natl Cancer Inst 89 497 505
26. M. Buyse P. Piedbois 2001 Should Dukes' B patients receive adjuvant chemotherapy? A statistical perspective Semin Oncol 28 Suppl1 20 24 (Pubitemid 32173100)
27. Sargent D, Sobrero A, Grothey A, et al. (2009) Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20 898 patients on 18 randomized trials. J Clin Oncol 27 (in press)
28. Meta-Analysis Group In Cancer 1998 Toxicity of 5-fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors J Clin Oncol 16 1 6
29. I. Durand-Zaleski B. Roche M. Buyse for the Meta-Analysis Group In Cancer 1997 Economic implications of hepatic arterial infusion in treatment of nonresectable colorectal liver metastases J Natl Cancer Inst 89 790 795 (Pubitemid 27242280)
30. I. Durand-Zaleski B. Roche M. Buyse for the Meta-Analysis Group In Cancer 1999 Economic implications of hepatic arterial infusion versus intravenous chemotherapy or symptom palliation in the treatment of nonresectable colorectal liver metastases Crit Rev Oncol Hematol 32 125 131 (Pubitemid 29528303)
31. A. DiLeo H. Bleiberg M. Buyse 2004 Is overall survival a realistic primary endpoint in advanced colorectal cancer? A critical assessment based on four clinical trials comparing fluorouracil plus leucovorin with the same treatment combined either with oxaliplatin or with irinotecan Ann Oncol 15 545 549 (Pubitemid 38559586)
32. A. DiLeo H. Bleiberg M. Buyse 2003 Overall survival is not a realistic endpoint for clinical trials in advanced solid tumors: a critical assessment based on recently reported phase III trials in colorectal and breast cancer (letter to the editor) J Clin Oncol 21 2045 2047
33. Burzykowski T, Molenberghs G, Buyse M (eds) (2005) The evaluation of surrogate endpoints. Springer, New York Berlin Heidelberg Tokyo
34. M. Buyse G. Molenberghs T. Burzykowski 2000 The validation of surrogate endpoints in meta-analyses of randomized experiments Biostatistics 1 49 68 (Pubitemid 33213521)
35. G. Molenberghs T. Burzykowski A. Alonso 2008 The metaanalytic framework for the evaluation of surrogate endpoints in clinical trials J Stat Plan Inference 138 432 449
36. T. Burzykowski G. Molenberghs M. Buyse 2001 Validation of surrogate endpoints in multiple randomized clinical trials with failure-time endpoints J R Stat Soc Ser C Appl Stat 50 405 422 (Pubitemid 33405905)
37. T. Burzykowski G. Molenberghs M. Buyse 2004 The validation of surrogate endpoints using data from randomized clinical trials: a case-study in advanced colorectal cancer J R Stat Soc Ser A 167 103 124 (Pubitemid 38341448)
38. T. Burzykowski M. Buyse 2006 Surrogate threshold effect: an alternative measure for meta-analytic surrogate endpoint validation Pharm Stat 5 173 186 (Pubitemid 44400217)
39. M. Buyse T. Burzykowski S. Michiels K. Carroll 2008 Individual- and trial-level surrogacy in colorectal cancer Stat Methods Med Res 17 5
40. D. Sargent S. Wieand D.G. Haller 2005 Disease-free survival (DFS) vs overall survival (OS) as a primary endpoint for adjuvant colon cancer studies: individual patient data from 20 898 patients on 18 randomized trials J Clin Oncol 23 8664 8670 (Pubitemid 46211509)
41. M. Buyse T. Burzykowski K. Carroll 2007 Progression-free survival is a surrogate for survival in advanced colorectal cancer J Clin Oncol 25 5218 5224 (Pubitemid 350232253)
42. M. Buyse P. Piedbois 1996 On the relationship between response to treatment and survival Stat Med 15 2797 2812 (Pubitemid 27011058)
43. M. Buyse P. Thirion R.W. Carlson for the Meta-Analysis Group in Cancer 2000 Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis Lancet 356 373 378 (Pubitemid 30487493)
44. Pignon JP, Buyse M, Piedbois P (2000) Critical issues in colorectal cancer randomized trials and meta-analyses. In: Bleiberg H, Rougier P, Wilke HJ (eds) Management of colorectal cancer, second edn. Martin Dunitz, London
45. P. Piedbois M. Buyse 2008 Endpoints and surrogate endpoints in colorectal cancer: a review of recent developments Curr Opin Oncol 20 466 471
46. C.J.A. Punt M. Buyse C.H. Köhne 2007 A proposal for the definition of endpoints for adjuvant trials in colorectal cancer J Natl Cancer Inst 99 998 1003
47. D.J. Sargent S. Patiyil G. Yothers for the Adjuvant Colon Cancer Endpoints 2007 Endpoints for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20 898 patients on 18 randomized trials J Clin Oncol 25 4569 4574 (Pubitemid 350035314)
48. T. Burzykowski M. Buyse D. Sargent 2008 Exploring and validating surrogate endpoints in colorectal cancer Lifetime Data Anal 14 54 64
49. C. Tournigand A. Cervantes A. Figer 2006 OPTIMOX1: a randomized study of FOLFOX4 or FOLOFOX7 with oxaliplatin in a stop-and-go fashion in advanced colorectal cancer - a GERCOR study J Clin Oncol 24 394 400 (Pubitemid 46630458)
50. C. Allegra P. Venook R. Goldberg 2007 Endpoints in advanced colon cancer clinical trials: a review and proposal J Clin Oncol 25 3572 3575 (Pubitemid 47372593)